Finance

Beta
Lists
9606:HKG
Duality Biotherapeutics Inc
HK$185.00
+3.29%
(+5.90) 1D
Jun 12, 3:45:52 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9606...
Open
HK$180.00
High
HK$190.20
Low
HK$173.40
Mkt. cap
16.72B
Avg. vol.
1.03M
Volume
1.07M
52-wk high
HK$563.50
52-wk low
HK$162.30
EPS
-HK$33.58
No. of employees
231
Open
HK$180.00
High
HK$190.20
Low
HK$173.40
Mkt. cap
16.72B
Avg. vol.
1.03M
Volume
1.07M
52-wk high
HK$563.50
52-wk low
HK$162.30
EPS
-HK$33.58
No. of employees
231
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to 9606 in the past 3 months
Strong Buy
Buy
6
Hold
0
Sell
0
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for 9606 in the last 3 months.
Highest
Current HK$185.00
HK$520.49 (+181.35%)
Average
HK$445.52 (+140.82%)
Lowest
HK$383.47 (+107.28%)
News stories
From sources across the web
About Duality Biotherapeutics Inc
CEO-
Employees231
Founded2019
Headquarters-
SectorBiotechnology
Websitedualitybiologics.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
614.47M
614.47M
311.40M
311.40M
Cost of goods sold
319.77M
319.77M
311.55M
311.55M
Cost of revenue
319.77M
319.77M
311.55M
311.55M
Research and development expenses
174.69M
174.69M
244.19M
244.19M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
62.77M
62.77M
44.53M
44.53M
Operating expense
236.61M
236.61M
288.00M
288.00M
Total operating expenses
556.38M
556.38M
599.55M
599.55M
Operating income
58.09M
58.09M
-288.15M
-288.15M
Other non operating income
-1.11B
-1.11B
6.86M
6.86M
EBT including unusual items
-1.04B
-1.04B
-260.48M
-260.48M
EBT excluding unusual items
-1.04B
-1.04B
-264.12M
-264.12M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-857.00K
-857.00K
-722.50K
-722.50K
Net income
-1.04B
-1.04B
-260.48M
-260.48M
Net profit margin
-168.75%
-168.75%
-83.65%
-83.65%
Earnings per share
-
-
-
-
Interest and investment income
19.73M
19.73M
29.92M
29.92M
Interest expense
-286.50K
-286.50K
-318.50K
-318.50K
Net interest expenses
19.45M
19.45M
29.60M
29.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
59.68M
59.68M
-286.03M
-286.03M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer